Zebra Capital Management LLC Vanda Pharmaceuticals Inc. Transaction History

Zebra Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$9.31 - $11.84 $3,118 - $3,966	-335 Reduced 2.22%	14,766 $161,000
Q1 2022 May 16, 2022	SELL	$10.84 - $16.55 $46,156 - $70,469	-4,258 Reduced 21.99%	15,101 $171,000
Q4 2021 Feb 14, 2022	SELL	$15.69 - $21.14 $55,213 - $74,391	-3,519 Reduced 15.38%	19,359 $304,000
Q3 2021 Nov 15, 2021	SELL	$15.35 - $21.27 $107,572 - $149,060	-7,008 Reduced 23.45%	22,878 $392,000
Q2 2021 Aug 16, 2021	SELL	$15.71 - $21.51 $32,566 - $44,590	-2,073 Reduced 6.49%	29,886 $642,000
Q1 2021 May 17, 2021	BUY	$13.42 - $20.28 $428,889 - $648,128	31,959 New	31,959 $480,000
Q4 2019 Feb 14, 2020	SELL	$12.38 - $17.47 $193,548 - $273,125	-15,634 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$12.27 - $15.79 $43,951 - $56,559	3,582 Added 29.72%	15,634 $208,000
Q2 2019 Aug 14, 2019	BUY	$13.37 - $18.85 $161,135 - $227,180	12,052 New	12,052 $170,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $264M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Zebra Capital Management LLC with notifications on news.